1
|
Sia D, Villanueva A, Friedman SL and
Llovet JM: Liver cancer cell of origin, molecular class, and
effects on patient prognosis. Gastroenterology. 152:745–761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-An update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Llovet JM, Zucman-Rossi J, Pikarsky E,
Sangro B, Schwartz M, Sherman M and Gores G: Hepatocellular
carcinoma. Nat Rev Dis Primers. 2:160182016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kato Y, Habas R, Katsuyama Y, Näär AM and
He X: A component of the ARC/Mediator complex required for TGF
beta/Nodal signalling. Nature. 418:641–646. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yang F, Vought BW, Satterlee JS, Walker
AK, Jim Sun ZY, Watts JL, DeBeaumont R, Saito RM, Hyberts SG, Yang
S, et al: An ARC/Mediator subunit required for SREBP control of
cholesterol and lipid homeostasis. Nature. 442:700–704. 2006.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhao M, Yang X, Fu Y, Wang H, Ning Y, Yan
J, Chen YG and Wang G: Mediator MED15 modulates transforming growth
factor beta (TGFβ)/Smad signaling and breast cancer cell
metastasis. J Mol Cell Biol. 5:57–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yang X and Yang F: Mediating lipid
biosynthesis: Implications for cardiovascular disease. Trends
Cardiovasc Med. 23:269–273. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nakatsubo T, Nishitani S, Kikuchi Y, Iida
S, Yamada K, Tanaka A and Ohkuma Y: Human mediator subunit MED15
promotes transcriptional activation. Drug Discov Ther. 8:212–217.
2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Berti L, Mittler G, Przemeck GK, Stelzer
G, Günzler B, Amati F, Conti E, Dallapiccola B, Hrabé de Angelis M,
Novelli G and Meisterernst M: Isolation and characterization of a
novel gene from the DiGeorge chromosomal region that encodes for a
mediator subunit. Genomics. 74:320–332. 2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shaikhibrahim Z, Offermann A, Halbach R,
Vogel W, Braun M, Kristiansen G, Bootz F, Wenzel J, Mikut R,
Lengerke C, et al: Clinical and molecular implications of MED15 in
head and neck squamous cell carcinoma. Am J Pathol. 185:1114–1122.
2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Shaikhibrahim Z, Menon R, Braun M,
Offermann A, Queisser A, Boehm D, Vogel W, Rüenauver K, Ruiz C,
Zellweger T, et al: MED15, encoding a subunit of the mediator
complex, is overexpressed at high frequency in castration-resistant
prostate cancer. Int J Cancer. 135:19–26. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Offermann A, Vlasic I, Syring I, Vogel W,
Ruiz C, Zellweger T, Rentsch CA, Hagedorn S, Behrends J, Nowak M,
et al: MED15 overexpression in prostate cancer arises during
androgen deprivation therapy via PI3K/mTOR signaling. Oncotarget.
8:7964–7976. 2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Klümper N, Syring I, Offermann A,
Shaikhibrahim Z, Vogel W, Müller SC, Ellinger J, Strauß A, Radzun
HJ, Ströbel P, et al: Differential expression of Mediator complex
subunit MED15 in testicular germ cell tumors. Diagn Pathol.
10:1652015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Schiano C, Casamassimi A, Rienzo M, de
Nigris F, Sommese L and Napoli C: Involvement of Mediator complex
in malignancy. Biochim Biophys Acta. 1845:66–83. 2014.PubMed/NCBI
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Ovchinnikov DA, Wan Y, Coman WB, Pandit P,
Cooper-White JJ, Herman JG and Punyadeera C: DNA methylation at the
novel CpG sites in the promoter of MED15/PCQAP gene as a biomarker
for head and neck cancers. Biomarker Insights. 9:53–60. 2014.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Gañán-Gómez I, Wei Y, Yang H,
Boyano-Adánez MC and García-Manero G: Oncogenic functions of the
transcription factor Nrf2. Free Radic Biol Med. 65:750–764. 2013.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Luo D, Wang Z and Wu J, Jiang C and Wu J:
The role of hypoxia inducible factor-1 in hepatocellular carcinoma.
Biomed Res Int. 2014:4092722014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Monga SP: β-catenin signaling and roles in
liver homeostasis, injury, and tumorigenesis. Gastroenterology.
148:1294–1310. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Rogacki K, Kasprzak A and Stępiński A:
Alterations of Wnt/β-catenin signaling pathway in hepatocellular
carcinomas associated with hepatitis C virus. Pol J Pathol. 1:9–21.
2015. View Article : Google Scholar
|
21
|
Li H, Wang W, Liu X, Paulson KE, Yee AS
and Zhang X: Transcriptional factor HBP1 targets P16(INK4A),
upregulating its expression and consequently is involved in
Ras-induced premature senescence. Oncogene. 29:5083–5094. 2010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Liao D and Johnson RS: Hypoxia: A key
regulator of angiogenesis in cancer. Cancer Metastasis Rev.
26:281–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wu XZ, Xie GR and Chen D: Hypoxia and
hepatocellular carcinoma: The therapeutic target for hepatocellular
carcinoma. J Gastroenterol Hepatol. 22:1178–1182. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J,
Zeng HY and Chang JY: The expression of HIF-1α in primary
hepatocellular carcinoma and its correlation with radiotherapy
response and clinical outcome. Mol Biol Rep. 39:2021–2029. 2012.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Lin D and Wu J: Hypoxia inducible factor
in hepatocellular carcinoma: A therapeutic target. World J
Gastroenterol. 21:12171–12178. 2015. View Article : Google Scholar : PubMed/NCBI
|